What is the veterinary market now and in the future ….

The objective of this study is to ascertain the potential size of the animal health market. While it is challenging to determine the exact size of this market, we can make an estimate by identifying the major players and the target animal populations. Our analysis will primarily focus on vaccines for cattle, poultry, and swine. 

It is worth noting that emulsion-based vaccines are not commonly used in pets due to concerns over side effects and the potential tumorigenicity caused by mineral oil. Therefore, our focus is on vaccines for livestock and other large animals. 

Given the complexity of the animal health vaccine market, our study aims to provide a rough estimate of the market size and potential demand for d vaccines. By doing so, we hope to contribute to a better understanding of this important area of research and development. 

Let’s talk about meat production in the world. We can learn a lot about it by looking at the numbers for poultry, beef, and pork production. By understanding these numbers and their future predictions, we can estimate the size of the veterinary vaccine market. In fact, the veterinary vaccine market is expected to grow from 13.6 billion US$ in 2023 to 28 billion US$ by 2032. That’s a big number and shows how important animal health is for the meat industry.

However, we should also consider the number of animals that are raised for protein consumption, like cows, pigs, and chickens. And while we didn’t include it in the market estimate, fish and other aquatic animals are also important for the meat industry. In fact, aquaculture (farming of fish and other aquatic animals) produced more than 178 million tons of meat in 2020 alone. That’s a lot! And the fish vaccine industry mainly uses emulsion based vaccines however total volume of sales of fish market is not the purpose of this research.

It’s important to look at the meat industry on a case-by-case basis to understand what drives each segment and how they are expected to grow in the future. To make it easier to understand, we’ve created a table below with some of the major industries and their expected growth by 2032.

Year	2022	2032
North America	13.8	14.2
Europe	10.7	10.3
Latin America	17.9	19.6
Africa	6.3	7.7
Asia	19.5	23
Oceania	3	3.2
Total	71.2	78
Drivers	0.8 to 1% growth in beef production

Year	2022	2032
North America	24.4	26.4
Europe	22.3	23.2
Latin America	28.4	32.9
Africa	6.7	8.7
Asia	53.3	63.2
Oceania	1.6	1.9
Total	136.7	156.3
Drivers:	5% growth poultry production
	Avian influenza the major pain point of the industry

Year	2022	2032
USA	15	15.1
Europe	28	28.4
Latin America	10	10.3
Asia	73	73
Africa	8.7	2
Oceania	0.5	0.6
Total	116.6	129.4
Drivers	Expected rise 1% world population
	African swine fever the Top problem

Beef	Poultry	Pork
USA	China	China
Brazil	USA	EU
China	BRZ	USA
Argentina	EU	Brazil
Australia	India	Russia
India (buffalo)	Russia	Vietnam
EU	Indonesia	South Corea
Russia		Mexico
Mexico

On average, an increase of 1 to 5% is observed in the global production animal population, with projections indicating a growth of 8% or more per year. The factors driving this growth are of considerable interest. Vaccines in animals have become increasingly important to prevent the spread of diseases among animal populations, protect animal health and welfare, and decrease the risk of zoonotic diseases transferring from animals to humans. The emergence of new diseases is a concern, and the role of pet vaccines in this context is worth exploring.

The growth of livestock can be attributed to several factors, including the increasing demand for protein-rich food. Additionally, sustainable agriculture practices have led to a heightened focus on raising healthier animals, further boosting the demand for livestock. The drive towards using antibiotics-free animals and the use of vaccines have also contributed to the growth of livestock. Furthermore, the emphasis on productivity and efficiency in livestock farming operations has helped improve livestock products’ yield and quality. Finally, there has been a growing demand for transparency in the supply chain, which has led to more accountability and traceability in the livestock industry.

Top diseases per species are the following:

Poultry:

1. Newcastle Disease: A highly contagious viral infection that can cause severe respiratory and nervous system symptoms in infected birds.
2. Avian Influenza: A highly contagious viral infection that can affect various bird species, including domestic poultry. It can cause a wide range of symptoms and has the potential to spread rapidly.
3. 3. Infectious Bronchitis: A viral respiratory disease that affects chickens of all ages. It can cause respiratory distress, decreased egg production, and poor growth rates in infected birds.
4. Infectious Bursal Disease (Gumboro): A viral disease that primarily affects young chickens and can lead to immunosuppression, making the birds more susceptible to other infections.
5. Marek’s Disease: A highly contagious viral disease that primarily affects young chickens. It can cause tumors, paralysis, and immunosuppression in infected birds.
6. Coccidiosis: in chickens is a common parasitic disease caused by the protozoan parasites of the genus Eimeria. It affects the intestinal tract of chickens and can lead to symptoms such as diarrhea, weight loss, and decreased egg production

Pork

1. African Swine Fever (ASF): African Swine Fever is a highly contagious viral disease that affects domestic and wild pigs. It can cause high fever, loss of appetite, internal bleeding, and high mortality rates in infected pigs. ASF is a significant concern in the pig industry due to its devastating effects on pig populations and trade restrictions imposed in affected regions.
2. Porcine Reproductive and Respiratory Syndrome (PRRS): PRRS is a viral disease that can cause reproductive failure in sows, respiratory problems in pigs of all ages, and increased mortality rates, particularly in piglets. PRRS can lead to significant economic losses in pig farming operations.
3. Swine Influenza: Swine influenza is caused by influenza viruses that affect pigs. It can cause respiratory symptoms, fever, lethargy, and decreased appetite in infected pigs. Swine influenza can also be transmitted to humans in some cases.
4. Porcine Epidemic Diarrhea Virus (PEDV): PEDV is a coronavirus that causes severe diarrhea and dehydration in pigs, particularly in young piglets. It can lead to high mortality rates in affected herds and significant economic losses for pig producers.
5. Foot-and-Mouth Disease (FMD): Foot-and-Mouth Disease is a highly contagious viral disease that affects cloven-hoofed animals, including pigs. It can cause fever, blisters on the feet and mouth, lameness, and decreased productivity in infected pigs. FMD outbreaks can result in trade restrictions and have serious economic consequences for the pig industry.

Bovine:

     1. Bovine Respiratory Disease (BRD): BRD is a complex respiratory disease caused by a combination of viral and bacterial pathogens. It is a significant health issue in            feedlot cattle and can result in pneumonia, reduced feed intake, weight loss, and even death in severe cases.

2. Bovine Viral Diarrhea (BVD): BVD is a viral disease that can cause a wide range of symptoms in cattle, including diarrhea, respiratory distress, reproductive issues, and immunosuppression. Persistent infection with BVD can result in chronic health problems and reduced productivity in affected animals.
3. Foot-and-Mouth Disease (FMD): Foot-and-Mouth Disease is a highly contagious viral disease that affects cloven-hoofed animals, including cattle. It can cause fever, blisters on the feet and mouth, lameness, and decreased milk production. FMD outbreaks can have significant economic consequences due to trade restrictions and loss of productivity.
4. Bovine Tuberculosis (bTB): Bovine Tuberculosis is a chronic bacterial disease caused by Mycobacterium bovis. It can affect cattle and other animals, as well as humans. Bovine TB can lead to weight loss, weakness, respiratory symptoms, and in severe cases, death. Control programs and surveillance are important in managing and preventing the spread of bTB.
5. Blackleg and clostridiums in general: Blackleg is a bacterial disease caused by Clostridium chauvoei that primarily affects cattle. It is characterized by sudden onset of lameness, swelling, and crepitus in affected muscles. Blackleg is a significant concern in cattle herds, especially in areas where the bacterium is present in the environment.

For most of the diseases that afflict the AH population, vaccines are available that can effectively control their spread. In addition to vaccination, proper animal husbandry practices can also contribute to reducing the incidence of these diseases. Nevertheless, some diseases remain difficult to manage, and when left unchecked, they can quickly escalate into large-scale outbreaks. Such outbreaks can cause significant losses in the AH population, underscoring the importance of continued research and development of new and effective disease control measures.

Market

The animal health market is witnessing a boom, with a staggering sales figure of 24 billion dollars. As per the latest report, the top 5 players in the market, Zoetis, Boehringer, Merck, Elanco, and Ceva, have together generated a revenue of 22 billion dollars worldwide. However, the most exciting aspect is the industry’s projected growth rate of 8-9% per year, which presents a promising opportunity for future investment and expansion. The biggest driver for such growth is the pet market; with the population aging and the reduction of the number of kids per family, people are adopting more and more Pets and “humanizing” the treatment of animals. We now see products such as Librela (Bedinvetmab) (Librela | Zoetis US (librelavetteam.com)) injectable Monoclonal antibody for the treatment of Osteoarthritis (OA) pain in dogs, and Canine Parvovirus Monoclonal antibody for the treatment of canine parvovirus (CPV) from Elanco (Canine Parvovirus Monoclonal Antibody (elanco.com)) with the estimated cost from US$ 3.000,00 to US$8.000,00 depending on the duration of the treatment.

Market division in the world

According to the latest sales data, the top three products that have generated over US$2 million in sales are parasiticides Bravecto (Home – us-bravecto-com) and Simparic trio (Simparica Trio | Zoetis Petcare (simparicatriodvm.com) followed by Aopquel (Apoquel® (oclacitinib tablet) I Zoetis US) an antiallergic medicine used to treat allergic dermatitis and atopic dermatitis in dogs. These products have been highly effective in improving pets’ health and quality of life. Additionally, a vaccine for porcine circovirus has secured the ninth spot on the list, indicating its widespread use in the agriculture industry. This data underscores the importance of investing in innovative and effective products that meet the evolving needs of pets and livestock.

The top 5 pharmaceutical companies generate half of their sales from vaccines and the other half from therapeutics and parasiticides medicine. However, the quantity of parasiticides sold is much higher than that of vaccines. The two best-selling parasiticides in the market are Nobivac (NOBIVAC® | Merck Animal Health USA (merck-animal-health-usa.com) for dogs and Ingelvac (Ingelvac CircoFLEX | Boehringer Ingelheim (boehringer-ingelheim.com) for swine.

As we examine the various regions of the world and their respective markets, we find that the three primary markets of interest are EUA, Europe, and Asia. Out of these, the pet market stands out as the largest one. However, the ruminant market takes the lead in size in Latin America. Regarding the products that are most in demand in this market, vaccines and parasiticides are the top sellers.

We also have the VPH market, which is mixed under the total seles but is extremely important and is considered the Veterinary Public Health market, which is composed of foot-and-mouth disease, bluetongue virus, and rabies (Control of Neglected Tropical Diseases (who.int)). Avian Influenza and African swine fever are among the most devastating diseases on animal populations, and of course, rabies can be transmitted among species. 

The market for veterinary products is impressive. Although it is not as vast as the human pharmaceutical market, it plays a crucial role in ensuring the health and well-being of animals, including pets, livestock, and poultry. The animal health market is highly dynamic, with frequent mergers and acquisitions and rapid technological advancements. It is more complex than the human vaccine business in many ways. 

For example, while there are only 26 vaccines available for humans, there are more than 20 viral and bacterial vaccines for poultry alone. This number can increase to over 40 to 50 vaccines, depending on the region and the strains of viruses and bacteria present. The animal health market is continuously growing, and the demand for new and improved products is increasing quickly. 

Moreover, the animal health market is highly regulated, and the development and approval of veterinary products take a long time and involve a lot of research and testing. The regulatory requirements for animal health products differ from those for human medicines, varying from country to country. Therefore, companies that operate in this market need to have a deep understanding of the regulatory framework and comply with the guidelines to ensure the safety and efficacy of their products.

In conclusion, the animal health market is a vital pharmaceutical industry segment requiring specialized knowledge, expertise, and technology. The market continuously evolves, and companies must be agile and innovative to keep up with the changing demands and regulatory landscape.

References:

Home – WOAH – World Organisation for Animal Health

Learn About AAAP

American Association of Bovine Practitioners (aabp.org)

Real Pork Makes a Real Difference – National Pork Board

Landing Page – Radius Global (radiusinsights.com)

IBISWorld – Industry Market Research, Reports, & Statistics

Veterinary vaccines: principles and applications (fao.org)

Marketing Analytics Leader | Analytic Partners

VetBro03eng (paho.org)